Abbott has announced that it has reached a significant settlement agreement with DexCom, Inc., resolving all ongoing patent disputes between the two companies related to continuous glucose monitoring ...

Financial giants have made a conspicuous bearish move on DexCom. Our analysis of options history for DexCom DXCM revealed 8 unusual trades. Delving into the details, we found 37% of traders were ...

In order from steepest decline to narrowest, the five unloved were Intel (NASDAQ: INTC), MongoDB (NASDAQ: MDB), Biogen (NASDAQ: BIIB), DexCom (NASDAQ: DXCM), and Microchip Technology (NASDAQ ...

DexCom faces challenges in 2024 due to competition and missteps, but the long-term outlook for continuous glucose monitors remains strong. Q3 revenue grew only 2% y/y to $994.2 million, with ...

Unless you’re an advocate for health tech or a diabetic like me, you may not have heard of Dexcom or Abbott, the two companies that form an oligopoly in the CGM space. Yet, you’re probably ...

Shares of the medical-device maker DexCom (NASDAQ: DXCM) are down by 37% this year. The diabetes-focused healthcare company disappointed investors with its second-quarter results, leading to a ...

DexCom, Inc. (DXCM), headquartered in California, is a leading player in the medical devices sector. Valued at a market cap of $30.4 billion, the company specializes in continuous glucose ...

DexCom DXCM has been analyzed by 9 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The table below offers a condensed view of their recent ...

Sam's Club is riding the dual waves of Walmart's (WMT) rise as budget-conscious consumers flock to wholesale retailers. Led by CEO Chris Nicholas, who started in September 2023, the wholesale club ...

Sam Goody, one of the record store giants from the golden age of physical media, may finally shutter its last remaining brick-and-mortar stores. The chain was one of the most prominent music ...